Cyberonics: Aspire Generator Recall Won’t Affect VNS Therapy Sales
This article was originally published in The Gray Sheet
Executive Summary
Cyberonics aims to submit a repair plan to FDA by April 2012 for its AspireHC vagus nerve stimulation therapy generator for epilepsy treatment following a recall of the device announced Aug. 15.
You may also be interested in...
New Products In Brief
Smith & Nephew’s PICO wound therapy, Intuitive Surgical’s EndoWrist One vessel sealer and Cyberonics’ re-designed AspireHC generator gain FDA market go-ahead. More new products.
News In Brief
Joint Commission urges caution in imaging
News In Brief
Joint Commission urges caution in imaging
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: